CoChat

Somatostatin receptor subtype gene expression in human endocrine gastroentero‐pancreatic tumours

JAÏS, P., TERRIS, B., RUSZNIEWSKI, P., LeROMANCER, M., REYL‐DESMARS, F., VISSUZAINE, C., CADIOT, G., MIGNON, M., LEWIN, M. J. M. · 1997 · European Journal of Clinical Investigation
Cited by 78

The DOI matches its Crossref record.

Abstract

Somatostatin and its analogues are now of current use in the management of endocrine gastroentero‐pancreatic (GEP) tumours for the purpose of inhibiting hormone hypersecretion, carrying scintigraphy imaging and attempting to slow down tumour growth. Recent molecular studies have revealed the existence of up to five membrane somatostatin receptor subtypes termed SSTR1–5. However, whether or not scintigraphy imaging and tumour characteristics are correlated with specific subtype(s) remains unclear. SSTR1–5 messenger RNA (mRNA) transcripts were investigated in 38 endocrine GEP tumours (32 islet cell tumours, six carcinoid) using reverse transcriptase polymerase chain reaction (RT‐PCR), and their distribution was analysed with respect to tumour characteristics and scintigraphy imaging. SSTR2, SSTR5 and SSTR4 were detected in most cases of endocrine GEP tumours (92%, 84%, and 82% respectively), but SSTR1 and SSTR3 were less frequently observed (66% and 50% respectively). No clear‐cut correlation was found between tumour characteristics and subtype mRNA distribution. Moreover, no differences in mRNA subtype distribution were found between the 17 tumours detected by scintigraphy and the four tumours not detected by this method. Somatostatin receptor mRNA subtypes are widely expressed in endocrine GEP tumours, but their distribution is not correlated with tumour characteristics or scintigraphy positivity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2362.1997.1740719.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 78

Metadata

Authors
JAÏS, P., TERRIS, B., RUSZNIEWSKI, P., LeROMANCER, M., REYL‐DESMARS, F., VISSUZAINE, C., CADIOT, G., MIGNON, M., & LEWIN, M. J. M.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
1997-08
Volume
27
Issue
8
Pages
639-644
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2064985050
Cited by
78
References
0
FWCI
1.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Somatostatin receptor subtype gene expression in human endocrine gastroentero‐pancreatic tumours. https://app.cochat.ai/papers/10.1046/j.1365-2362.1997.1740719.x
The paper
JAÏS, P., TERRIS, B., RUSZNIEWSKI, P., LeROMANCER, M., REYL‐DESMARS, F., VISSUZAINE, C., CADIOT, G., MIGNON, M., & LEWIN, M. J. M. (1997). Somatostatin receptor subtype gene expression in human endocrine gastroentero‐pancreatic tumours. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.1997.1740719.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.